Regeneron Pharmaceuticals Inc (REGN) earnings · P/E 20, rev $14.34B
These earnings events as JSON? API free 100/dayRegeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
This REGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 19.7.
When the next REGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 1.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full REGN research stays on the stock page; the tape stays on the quote page.
REGN earnings FAQ
What are REGN's latest revenue and net income?
Latest cached Regeneron Pharmaceuticals Inc (REGN) revenue for Dec 31, 2025 was $14.34B. Net income was $4.50B. Statements: https://lician.com/financials/regn
What is REGN's latest diluted EPS?
Latest cached Regeneron Pharmaceuticals Inc (REGN) diluted EPS for Dec 31, 2025 was $41.48.
What period does the latest REGN earnings print cover?
The latest cached Regeneron Pharmaceuticals Inc (REGN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did REGN revenue change from the prior cached period?
Cached Regeneron Pharmaceuticals Inc (REGN) revenue was up 1.0% from $14.20B (Dec 31, 2024) to $14.34B (Dec 31, 2025). Statements: https://lician.com/financials/regn
What is REGN's P/E ratio?
Regeneron Pharmaceuticals Inc (REGN) trailing P/E is 19.7 on the latest cached fundamentals snapshot.
Where are REGN earnings listed?
Cached earnings facts for Regeneron Pharmaceuticals Inc (REGN) are listed at https://lician.com/earnings/regn. Statements: https://lician.com/financials/regn
Not investment advice.